News Article

Saneron and Henry Ford Health: Cell Therapy Combo Aids Stroke
Date: Mar 19, 2013
Source: ( click here to go to the source)

Featured firm in this article: Saneron CCEL Therapeutics Inc of Tampa, FL

Newswise — TAMPA, Fla. -- March 19, 2013 -- Researchers at the Henry Ford Health System (Detroit, MI) and colleagues at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, have found that when human umbilical cord blood cells (HUCBCs) were transplanted into test rats modeled with stroke, the addition of Simvastatin to the HUCBCs significantly increased the therapeutic benefit of the HUCBCs.